METASTATIC PANCREATIC CANCER
Clinical trials for METASTATIC PANCREATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PANCREATIC CANCER trials appear
Sign up with your email to follow new studies for METASTATIC PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early-Stop trial tests new drug combo for tough pancreatic cancer
Disease control TerminatedThis study tested whether adding an experimental drug called NIS793 to a standard chemotherapy combination (FOLFIRINOX) could help people with metastatic pancreatic cancer. The goal was to see if the new combination was safe and could help shrink tumors enough for surgery. The tr…
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: PHASE1 • Sponsor: Colin D. Weekes, M.D., PhD • Aim: Disease control
Last updated Apr 01, 2026 21:41 UTC
-
Targeted pill trial for aggressive pancreatic cancer ends early
Disease control TerminatedThis study tested whether a daily pill called niraparib could help control advanced pancreatic cancer that had spread and had specific genetic changes. The trial was designed for people who hadn't yet received chemotherapy for their metastatic cancer and had mutations in certain …
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: PHASE2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Terminated trial tested unusual drug mix for tough liver cancers
Disease control TerminatedThis study tested whether combining three existing drugs—nivolumab (an immunotherapy), tadalafil (a blood pressure/erectile dysfunction drug), and oral vancomycin (an antibiotic)—could shrink advanced liver cancers. It was for adults whose liver cancer (either starting in the liv…
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Terminated early: new drug combo tested in tough pancreatic cancer cases
Disease control TerminatedThis early-stage trial aimed to test the safety of a new drug, YL-13027, when given alongside two standard chemotherapy drugs (gemcitabine and nab-paclitaxel) to patients with metastatic pancreatic cancer that had stopped responding to prior treatment. The study was designed to f…
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Could a daily pill fight Cancer's devastating weight loss?
Symptom relief TerminatedThis study tested whether a daily pill called anamorelin could help prevent severe weight loss and poor appetite in people with advanced pancreatic cancer who were starting chemotherapy. The goal was to see if the drug could help patients maintain their weight and strength to bet…
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: PHASE2 • Sponsor: Lahey Clinic • Aim: Symptom relief
Last updated Apr 01, 2026 14:42 UTC